General Information
Version
6.11
Product name
(R)-(+)-Styrene oxide
CAS No.
20780-53-4
REACH No
is
Emergency telephone
900-868538 (CHEMTREC España
Icons in SDS
Company Information
company name
Merck Life Science S.L
e-mail address of the competent person responsible for the Safety Data Sheet
serviciotecnico@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H312, H319, H350
Hazard statements
Code
Statements
H312
Harmful in contact with skin
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H312: Harmful in contact with skin. Eye irritation, (Category 2) H319: Causes serious eye irritation. Carcinogenicity, (Category 1B) H350: May cause cancer.
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H312 Harmful in contact with skin. H319 Causes serious eye irritation. H350 May cause cancer. Reduced Labeling (<= 125 ml) H350 May cause cancer.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
